| Entry |
|
|---|
| Name |
Masoprocol (USAN/INN);
meso-Nordihydroguaiaretic acid;
Actinex (TN) |
|---|
| Formula |
C18H22O4
|
|---|
| Exact mass |
302.1518
|
|---|
| Mol weight |
302.3649
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
|
|---|
| Efficacy |
Anti-inflammatory, Antineoplastic |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX10 Masoprocol
D04862 Masoprocol (USAN/INN)
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
EGFR family
EGFR
D04862 Masoprocol (USAN/INN)
Cytokines and receptors
Cytokines
Growth factors (RTK-binding)
IGF1
D04862 Masoprocol (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 22
1 C8y C 12.3200 -17.4300
2 C8y C 12.3200 -18.8300
3 C8x C 13.5324 -19.5300
4 C8x C 14.7449 -18.8300
5 C8y C 14.7449 -17.4300
6 C8x C 13.5324 -16.7300
7 C1b C 15.9760 -16.7190
8 O1a O 11.1076 -19.5300
9 C1c C 17.1812 -17.4147
10 C1c C 18.3635 -16.7319
11 C1b C 19.5575 -17.4212
12 C1a C 17.1816 -18.8296
13 O1a O 11.1076 -16.7300
14 C1a C 18.3635 -15.3302
15 C8y C 20.7454 -16.7352
16 C8x C 21.9365 -17.4229
17 C8y C 23.1490 -16.7229
18 C8y C 23.1490 -15.3229
19 C8x C 21.9579 -14.6352
20 C8x C 20.7455 -15.3352
21 O1a O 24.3740 -14.6155
22 O1a O 24.3802 -17.4339
BOND 23
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 2 8 1
9 7 9 1
10 9 10 1
11 10 11 1
12 9 12 1 #Down
13 1 13 1
14 10 14 1 #Up
15 11 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 18 19 1
20 19 20 2
21 15 20 1
22 18 21 1
23 17 22 1
|
|---|
